This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

TIDES eBook: mRNA Automation and Analytical Technologies

Share this article

This spring, TIDES held a hybrid event in Boston presenting the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.

In this eBook we not only dive into the newest technological advances in the mRNA industry, but also delve into analytical methods, manufacturing techniques, industry roadmaps, and more. The next pages include insights from Asahi Kasei Bioprocess, Moderna, BioNTech, Sarepta Therapeutics, Biogen, and more.

Read or download the report above (or click here).

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

19 - 21 Mar 2024, Kyoto, Japan

Industry leaders and service providers share cutting-edge content and company expertise across the Oligonucleotide, Peptide, mRNA and Drug Delivery spectrum

Go to site